AN AGROCHEMICAL COMBINATION

Information

  • Patent Application
  • 20250113826
  • Publication Number
    20250113826
  • Date Filed
    October 17, 2022
    3 years ago
  • Date Published
    April 10, 2025
    8 months ago
Abstract
Described herein are combinations of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof with at least two herbicides. The resulting combinations may be synergistic. Also described are compositions, methods of use and kit-of-parts of the same.
Description
FIELD OF THE INVENTION

The present invention relates to an herbicidal combination for controlling weeds. More particularly, the present invention relates to synergistic herbicidal combinations, compositions, kits-in-part and method for controlling undesirable weeds.


BACKGROUND OF THE INVENTION

Weeds are undesirable plants that are detrimental to agriculture and significantly affect crop yields. Farmers use various types of herbicides to control weeds. Herbicides with varied modes of action are generally combined, which allows for broader spectrum of control and managing resistance to herbicides. However, the combinations currently known are not sufficient to control the resistant and persistent weeds.


Additionally, the combination of herbicides may not always result in the desired effect. Combinations of herbicides may result in an additive effect or an antagonistic effect. It may also result in phytotoxicity to the crops making it an undesirable combination. Consequently, herbicides need to be carefully selected so that they can be combined to offer a synergistic effect that would control weeds while having no phytotoxic effect on the crop and reduce the chances of the weeds developing resistance to a particular herbicide.


Accordingly, there is a need in the art for a synergistic herbicidal combination, composition, method and kits for protecting crops from persistent weeds, which helps in resistance management, reduces dosage of herbicides used and that has excellent residual effects.


OBJECTIVE OF THE INVENTION

It is an objective of the present invention to provide a synergistic combination for controlling weeds.


It is an objective of the present invention to provide a combination for efficient weed control, weed suppression and eradication.


It is an object of the present invention to provide a combination of highly effective herbicidal actives for selective and non-selective weed control.


It is another object of the present invention to provide a synergistic herbicidal combination to control, suppress or prevent a wide spectrum of weeds and target plants, both dicotyledonous and monocotyledonous, broad-leaved, and grassy weeds.


It is an objective of the present invention to provide a synergistic combination for controlling weeds, comprising glufosinate or L-glufosinate and at least two herbicides selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone class of herbicides, and/or uracil class of herbicides.


It is an objective of the present invention to provide a composition for controlling weeds, comprising glufosinate or L-glufosinate and at least two herbicides selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone class of herbicides, and/or uracil class of herbicides.


It is an objective of the present invention to provide solid or liquid formulations for controlling weeds.


It is an objective of the present invention to provide a method of controlling weeds, by application of a synergistic herbicidal combination comprising glufosinate or L-glufosinate and at least two herbicides selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone class of herbicides, and/or uracil class of herbicides.


It is an objective of the present invention to provide a method for increasing yield in a crop by application of a synergistic combination.


It is an objective of the present invention to provide a method for improving the plant health by application of a synergistic combination at the desired locus.


It is an objective of the present invention to provide a combination or composition for use in controlling undesirable vegetation.


Additionally, it is an object of the invention to provide a method of controlling resistant varieties of weeds with a suitable herbicidal combination.


It is an object of the present invention to provide a combination of highly effective herbicidal actives for an efficient burn-down program.


It is an objective of the present invention to provide a kit-of-parts comprising a plurality of components.


SUMMARY OF THE INVENTION

In an aspect, the present invention provides a combination for controlling the growth of undesirable vegetation, said combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides.


In another aspect, there is provided a composition for controlling the growth of undesirable vegetation, the composition comprising glufosinate, salts or esters thereof, at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides;


      and at least one agrochemically suitable excipient.


In a preferred embodiment, the glufosinate, salts or esters thereof, is L-glufosinate, salts or esters thereof.


Preferably, the second and third herbicides may be selected from within the same class of herbicides.


Preferably, the second and third herbicides may be selected from within different classes of herbicides.


In accordance with another aspect, the weight ratio of glufosinate and the at least two herbicides ranges from 1:100:100 to 100:1:1.


In accordance with another aspect, the weight ratio of glufosinate and the at least two herbicides ranges from 1:75:75 to 75:1:1.


In accordance with another aspect, there is provided a method of controlling the growth of undesirable vegetation, the method comprising treating the locus at which control is desired with a synergistic combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides.


Preferably, the second and third herbicides may be selected from within the same class of herbicides.


Preferably, the second and third herbicides may be selected from within different classes of herbicides.


Preferably, the glufosinate, salts or esters thereof, is L-glufosinate, salts or esters thereof.


Preferably, the second herbicide is selected from the nitrophenyl ether class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the imidazolinone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the organophosphorus class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the dicarboximide class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the phenoxyacetic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the pyridine class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the cyclohexene oxime class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the aryloxyphenoxypropionic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the triazolone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the uracil class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


In accordance with another aspect, there is provided a method of controlling the growth of undesirable vegetation, the method comprising treating the locus with a synergistic combination of glufosinate, an herbicide selected from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides.


In accordance with another aspect, the weight ratio of glufosinate, the herbicide selected from the imidazolinone class of herbicides, and the herbicide selected from the triazolone class of herbicides ranges from 1:100:100 to 100:1:1.


In accordance with another aspect, the weight ratio of glufosinate, the herbicide selected from the imidazolinone class of herbicides, and the herbicide selected from the triazolone class of herbicides ranges from 1:75:75 to 75:1:1.


In accordance with yet another aspect, the combinations, compositions and methods of the present invention are used for controlling weeds in a range of crops.


In accordance with yet another aspect, there is provided a kit-of-parts comprising a plurality of components that may be admixed before use.







DETAILED DESCRIPTION OF THE INVENTION

Discussed below are some representative embodiments of the present invention. The invention in its broader aspects is not limited to the specific details and representative methods. Illustrative examples are described in this section in connection with the embodiments and methods provided.


For the purposes of the following detailed description, it is to be understood that the invention may assume various alternative variations and step sequences, except where expressly specified to the contrary. Moreover, other than in any operating examples, or where otherwise indicated, all numbers expressing, for example, quantities of materials/ingredients used in the specification are to be understood as being modified in all instances by the term “about” and is meant to encompass variations of ±10%, ±5%, ±1%, ±0.5%, or even ±0.1% of the specified value as well as the specified value.


It is to be noted that, as used in the specification, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to a composition containing “a surfactant” includes a mixture of two or more surfactants. It should also be noted that the term “‘or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise. The terms “emulsifier” and “surfactant” mean essentially the same thing and may be used interchangeably. Further, the terms “composition” or “formulation” also mean essentially the same thing and may be used interchangeably.


The terms “preferred” and “preferably” refer to embodiments of the invention that may afford certain benefits, under certain circumstances.


As used herein, the terms “comprising” “including,” “having,” “containing,” “involving,” and the like are to be understood to be open-ended, i.e., to mean including but not limited to.


The expression of various quantities in terms of “%” or “% w/w” means the percentage by weight of the total solution or composition unless otherwise specified.


The terms “plants” and “vegetation” include, but are not limited to, germinant seeds, emerging seedlings, plants emerging from vegetative propagules, and established vegetation. The term ‘plants’ refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage and fruits. The term “weed” refers to unwanted vegetation and includes any plant which grows where it is not wanted, including pesticide resistant plants. In the broadest sense, the term “weed” refers to plants which grow in locations in which they are not desired. In other words, a “weed” is a plant in which in the context of a crop is undesirable due to competition for water, nutrients, sunlight, soil, etc. The term may also refer to crop plants which are undesirable at a location.


The terms “undesirable vegetation”, “harmful plants”, “unwanted plants”, “weeds” and “weed species”, as used herein, are synonyms.


Typically, the combinations/compositions of the present invention are applied to the targeted weed or to their locus or to the crop/plant. The term “locus” as used herein shall denote the vicinity of a desired crop in which weed control, typically selective weed control is desired.


The locus includes the vicinity of desired crop plants wherein the weed infestation has either emerged or is yet to emerge. The term crop shall include a multitude of desired crop plants or an individual crop plant growing at a locus. The said locus could be a weed, an area adjacent to the weed, soil adapted to support growth of the weed, a root of the weed and/or foliage of the weed. The ‘locus’ is intended to include soil, seeds, and seedlings as well as established vegetation.


In any aspect or embodiment described hereinbelow, the phrase comprising may be replaced by the phrases “consisting of’ or “consisting essentially of’ or “consisting substantially of’. In these aspects or embodiment, the combination or composition described includes or comprises or consists of or consists essentially of or consists substantially of the specific components recited therein, to the exclusion of other herbicides or fungicides or insecticide or plant growth promoting agents or adjuvants, or excipients not specifically recited therein.


The present invention, in all its aspects, is described in detail as follows:


Glufosinate (phosphinothricin; DL-homoalanin-4-yl(methyl)phosphinic acid) is a racemic phosphinico amino acid (Hoerlein, G. 1994; glufosinate (Phosphinothricin), a natural amino acid with unexpected herbicidal properties. Rev. of Environmental Contamination and Toxicology 138, 73-145). Its ammonium salt (glufosinate-ammonium) is widely used as a non-selective herbicide and is the active ingredient of the commercial herbicide formulations Basta™, Buster™, Challenge™, Conquest™, Dash™, Final™, Finale™, Liberty™ and Ignite™. The L-isomer of glufosinate is a structural analogue of glutamate and, therefore, is a competitive inhibitor of the enzyme glutamine synthetase (GS) of bacteria and plants (Bayer et al, 1972, Phosphinothricin and phosphinothricyl-alanyl-alanin. Helv. Chim. Acta 55, 224-239; Leason et al., 1982, Inhibition of pea leaf glutamine synthetase by methioninsulfoximine, Phosphinothricin and other glutamate analogs. J. Phytochem. 21, 855-857). The D-isomer is not a GS inhibitor and is not herbicidally active.




embedded image


Fig. 1. Chemical structures of D-glufosinate and L-glufosinate.


It has surprisingly been found by the present inventors that a range of weeds can be completely controlled by the combination of glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides.


More surprisingly, it was found that this combination, between glufosinate, salts or esters thereof, and at least two herbicides provided synergistic effect in controlling a range of weeds. The degree of synergistic enhancement in efficacy of the above combination towards control of weeds was unpredictable and unexpected.


As used herein, the term “glufosinate” refers to any molecule which is a racemic phosphinico amino acid or a salt thereof. The term also includes forms and isomers of glufosinate such as glufosinate-p (L-glufosinate), D-glufosinate, and sodium, potassium or ammonium salts thereof. The term can generically refer to any form of glufosinate or its salt such as solvates, hydrates, anhydrous form, polymorph forms, pseudo polymorph forms, amorphous form or mixture thereof.


Preferably, the herbicide glufosinate, salts or esters thereof, used in any aspect or embodiment described herein may be replaced by, or used interchangeably as, its L-isomer i.e. L-glufosinate, salts or esters thereof.


As used herein, the term “L-glufosinate” refers to the L-isomer of glufosinate or a salt thereof. The L-isomer of glufosinate is a structural analogue of glutamate and, therefore, is a competitive inhibitor of the enzyme glutamine synthetase (GS) of bacteria and plants. The L-enantiomer of glufosinate acts by inhibition of glutamine synthetase thereby causing accumulation of toxic levels of ammonium ion and indirectly stopping photosynthesis. It is also known as phosphinothricin or (S)-2-amino-4-(hydroxy(methyl)phosphonyl)butanoic acid. The term as used herein includes free acid form, salts and ester forms of L-glufosinate. The term very commonly covers derivatives such as salts and esters of L-glufosinate. The term can generically refer to any form of L-glufosinate or its salt such as free acid, solvates, hydrates, anhydrous form, polymorph forms, pseudo polymorph forms, amorphous form or mixture thereof, and sodium, potassium or ammonium salts. The term “L-glufosinate or a salt thereof” encompasses any salt of L-glufosinate, preferable sodium, potassium and ammonium salts. The salts of L-glufosinate such as monosodium salt, disodium salt, monopotassium salt, dipotassium salt, calcium salt, ammonium salt, —NH3(CH3)+ salt, —NH2(CH3)2+ salt, —NH(CH3)3+ salt, —NH(CH3)2(C2H4OH)+ salt, and —NH2(CH3)(C2H4OH)+ salt are included in the definition. The agronomically acceptable salts include L-glufosinate-ammonium, L-glufosinate-sodium, and L-glufosinate-potassium. The term may also refer to an isomeric (racemic) mixture of L-glufosinate, D-glufosinate and salts thereof, wherein the content of L-glufosinate or a salt thereof in the mixture is 70% or greater, preferably 80% or greater and more preferably 90% or greater. Typically, the ratio of L-glufosinate:D-glufosinate can be in the range from about 95:5 to about 99.9:0.1.


Therefore, in an embodiment, the preferred glufosinate, salts or esters thereof herbicide is L-glufosinate, salts or esters thereof.


The term ‘herbicide’ as used herein denotes a compound which controls or modifies the growth of plants. The term ‘herbicidally effective amount’ indicates the quantity of such a compound or combination of such compounds which is capable of producing a controlling or modifying effect on the growth of plants. Controlling effects include all deviation from natural development, for example: killing, retardation, leaf burn, albinism, dwarfing etc.


In an embodiment, the present invention provides an herbicidal combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides.


In an embodiment, the present invention provides an herbicidal combination for controlling the growth of undesirable vegetation, said combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides.


In a preferred embodiment, glufosinate, salts or esters thereof is L-glufosinate, salts or esters thereof.


In an embodiment, the present invention provides an herbicidal combination for controlling the growth of undesirable vegetation, said combination comprising L-glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides.


Preferably, the second and third herbicides may be selected from within the same class of herbicides.


Preferably, the second and third herbicides may be selected from within different classes of herbicides.


Preferably, the glufosinate, salts or esters thereof may be L-glufosinate, salts or esters thereof.


Preferably, the second herbicide is selected from the nitrophenyl ether class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the imidazolinone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the organophosphorus class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the dicarboximide class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the phenoxyacetic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the pyridine class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the cyclohexene oxime class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the aryloxyphenoxypropionic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the triazolone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


Preferably, the second herbicide is selected from the uracil class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.


In an embodiment, said combinations of the present disclosure are tank-mix combinations.


In an embodiment, nitrophenyl ether class herbicide is selected from the group consisting of oxyfluorfen, acifluorfen, aclonifen, bifenox, chlomethoxyfen, chlornitrofen, etnipromid, fluorodifen, fluoroglycofen, fluoronitrofen, fomesafen, fucaomi, furyloxyfen, halosafen, lactofen, nitrofen, nitrofluorfen, and combinations thereof.


In a preferred embodiment, the nitrophenyl ether class herbicide is oxyfluorfen.


In a preferred embodiment, the nitrophenyl ether class herbicide is acifluorfen.


In a preferred embodiment, the nitrophenyl ether class herbicide is fomesafen.


In a preferred embodiment, the nitrophenyl ether class herbicide is aclonifen.


In an embodiment, the imidazolinone class herbicide is selected from the group consisting of imazethapyr, imazamethabenz, imazamox, imazapic, imazapyr, imazaquin and combinations thereof.


In a preferred embodiment, the imidazolinone class herbicide is imazethapyr.


In a preferred embodiment, the imidazolinone class herbicide is imazamox.


In a preferred embodiment, the imidazolinone class herbicide is imazapyr.


In a preferred embodiment, the imidazolinone class herbicide is imazapic.


In an embodiment, the organophosphorous class of herbicide is selected from the group consisting of glyphosate, amiprofos-methyl, amiprophos, anilofos, bensulide, bilanafos, butamifos, clacyfos, 2,4-DEP (2,4-Dichlorophenoxyethylphosphite), DMPA (O-(2,4-Dichlorophenyl) O-Methyl Isopropylphosphoramidothioate), EBEP (ethyl bis(2-ethylhexyl)phosphinate), fosamine, huangcaoling, piperophos, shuangjiaancaolin and combinations thereof.


In a preferred embodiment, the organophosphorous class herbicide is glyphosate.


In an embodiment, the dicarboximide class herbicide is selected from the group consisting of flumioxazin, cinidon-ethyl, flumezin, flumiclorac, flumipropyn, and combinations thereof.


In a preferred embodiment, the dicarboximide class herbicide is flumioxazin.


In an embodiment, the phenoxyacetic class herbicide is selected from the group consisting of clacyfos, 2,4-D, 4-CPA (p-Chlorophenoxyacetic acid), 3,4-DA, MCPA (2-METHYL-4-CHLOROPHENOXYACETIC ACID), MCPA-thioethyl, 2,4,5-T, and combinations thereof.


In a preferred embodiment, the phenoxyacetic class herbicide is 2,4-D.


In a preferred embodiment, the phenoxyacetic class herbicide is MCPA.


In an embodiment, pyridine class herbicide is selected from the group consisting of triclopyr, aminopyralid, cliodinate, clopyralid, diflufenican, dithiopyr, florpyrauxifen, flufenican, fluroxypyr, halauxifen, haloxydine, picloram, picolinafen, pyriclor, pyroxsulam, thiazopyr, xyloxadine, and combinations thereof.


In a preferred embodiment, the pyridine class herbicide is triclopyr.


In a preferred embodiment, the pyridine class herbicide is diflufenican.


In a preferred embodiment, the pyridine class herbicide is flufenican.


In a preferred embodiment, the pyridine class herbicide is fluroxypyr.


In a preferred embodiment, the pyridine class herbicide is picloram.


In a preferred embodiment, the pyridine class herbicide is pyroxsulam.


In an embodiment, the cyclohexene oxime class herbicide is selected from the group consisting of clethodim, alloxydim, butroxydim, cloproxydim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim, and combinations thereof.


In a preferred embodiment, the cyclohexene oxime class herbicide is clethodim.


In an embodiment, the aryloxyphenoxypropionic class herbicide is selected from the group consisting of haloxyfop, chlorazifop, clodinafop, clofop, cyhalofop, diclofop, fenoxaprop, fenoxaprop-P, fenthiaprop, fluazifop, fluazifop-P, haloxyfop-P, isoxapyrifop, kuicaoxi, metamifop, propaquizafop, quizalofop, quizalofop-P, quizalofop-ethyl, quizalofo-P-tefuryl, trifop, and combinations thereof.


In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is haloxyfop or haloxyfop-P.


In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is clodinafop.


In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is fenoxaprop or fenoxaprop-P.


In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is quizalofop or quizalofop-P.


In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is quizalofop-ethyl or quizalofop-P-tefuryl.


In an embodiment, the triazolone class herbicide is selected from the group consisting of carfentrazone, amicarbazone, bencarbazone, flucarbazone, ipfencarbazone, propoxycarbazone, sulfentrazone, thiencarbazone and combinations thereof.


In a preferred embodiment, the triazolone class herbicide is carfentrazone.


In a preferred embodiment, the triazolone class herbicide is amicarbazone.


In a preferred embodiment, the triazolone class herbicide is flucarbazone.


In a preferred embodiment, the triazolone class herbicide is ipfencarbazone.


In a preferred embodiment, the triazolone class herbicide is sulfentrazone.


In an embodiment, the uracil class herbicide is selected from the group consisting of bromacil, isocil, lenacil, terbacil, benzfendizone, butafenacil, epyrifenacil, flupropacil, saflufenacil, tiafenacil, and combinations thereof.


In a preferred embodiment, the uracil class herbicide is saflufenacil.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation, said combination comprising glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:100:100 to 100:1:1.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation, said combination comprising L-glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:100:100 to 100:1:1.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation, said combination comprising glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:75:75 to 75:1:1.


In an embodiment, preferably, the weight ratio of glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:50:50 to 50:1:1.


More preferably, the weight ratio between glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:25:25 to 25:1:1, more preferably 1:10:10 to 10:1:1.


In a preferred embodiment, the weight ratio between glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:5:5 to 5:1:1, even more preferably 1:2:2 to 2:1:1.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation, said combination comprising L-glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:75:75 to 75:1:1.


In an embodiment, preferably, the weight ratio of L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:50:50 to 50:1:1.


More preferably, the weight ratio between L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:25:25 to 25:1:1, more preferably 1:10:10 to 10:1:1.


In a preferred embodiment, the weight ratio between L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:5:5 to 5:1:1.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation, said combination comprising glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:100 to 100:1.


Preferably, the weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.


In a yet another preferred embodiment, the weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:10 to 10:1, more preferably 1:5 to 5:1 and even more preferably 1:2 to 2:1.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation, said combination comprising L-glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of L-glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:100 to 100:1.


Preferably, the weight ratio of L-glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.


In a yet another preferred embodiment, the weight ratio of L-glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:10 to 10:1, more preferably 1:5 to 5:1.


According to an embodiment, the combinations of the present invention are illustrated below in Table 1.









TABLE 1







Exemplary combinations of glufosinate, salts or esters thereof or L-glufosinate, salts


or esters thereof with at least two herbicides














Ratio of Herbicide1:






Herbicide 2 in






combination and
Ratio of Herbicide2:





Herbicide 1:Herbicide
Herbicide 3 in


Herbicide 1
Herbicide 2
Herbicide 3
3 in combination
combination





glufosinate, salts
nitrophenyl
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
herbicide different
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,

from component 1
more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
nitrophenyl
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
ether herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide different
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,

from component 1
more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
imidazolinone
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters

different from
50:1, even more
50:1, even more


thereof

component 1
preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
aryloxyphenoxy-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
propionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
organophosphorous
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide different
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,

from component 1
more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
dicarboximide
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide different
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,

from component 1
more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
phenoxyacetic
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
different from
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,

component 1
more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
pyridine
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide
different from
more preferably 1:50 to
more preferably 1:50 to


salts or esters

component 1
50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
oxime
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
cyclohexene
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters
oxime

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


thereofor L-
herbicide

more preferably 1:50 to
more preferably 1:50 to


glufosinate, salts


50:1, even more
50:1, even more


or esters thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters

different from
50:1, even more
50:1, even more


thereof

component 1
preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
aryloxyphenoxy-
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
propionic

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,
herbicide

more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide different
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,

from component 1
more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
triazolone
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
nitrophenyl ether
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
imidazolinone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
organophosphorous
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
dicarboximide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
phenoxyacetic
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
pyridine herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide

preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
cyclohexene
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
oxime herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
aryloxyphenoxypro-
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
pionic herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
triazolone
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
herbicide
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,


more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.


glufosinate, salts
uracil
uracil herbicide
100:1 to 1:100,
100:1 to 1:100,


or esters thereof
herbicide
different from
preferably 1:75 to 75:1,
preferably 1:75 to 75:1,


or L-glufosinate,

component 1
more preferably 1:50 to
more preferably 1:50 to


salts or esters


50:1, even more
50:1, even more


thereof


preferably 1:25 to 25:1,
preferably 1:25 to 25:1,





even more preferably
even more preferably





1:10 to 10:1 and most
1:10 to 10:1 and most





preferably 1:5 to 5:1.
preferably 1:5 to 5:1.









Preferably, the following exemplary combinations of the invention as illustrated in Table 2 were synergistic:













TABLE 2








Ratio of Herbicide






1:Herbicide 2 in





combination and
Ratio of Herbicide





Herbicide 1:Herbicide 3
2:Herbicide 3 in


Herbicide 1
Herbicide 2
Herbicide 3
in combination
combination







Glufosinate,
Oxyfluorfen
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Glyphosate
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1 even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Oxyfluorfen
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Glyphosate
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Acifluorfen
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25





to 25:1, even more
to 25:1, even more


salts or esters


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and


thereof


most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Glyphosate
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fomesafen
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Glyphosate
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Aclonifen
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Glyphosate
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazethapyr
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Glyphosate
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazamox
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Imazapic
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Glyphosate
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Imazapyr
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10: 1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Glyphosate
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flumioxazin
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
2,4-D
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
MCPA
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Diflufenican
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flufenican
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Fluroxypyr
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Picloram
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Picloram
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Pyroxsulam
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Pyroxsulam
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clethodim
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Clodinafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Haloxyfop
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Clodinafop
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Quizalafop
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Quizalafop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Carfentrazone
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Amicarbazone
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Flucarbazone
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Sulfentrazone
Saflufenacil
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Acifluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Fomesafen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Aclonifen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Imazamox
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Imazethapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Imazapyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Oxyfluorfen
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Flumioxazin
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
2,4-D
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
MCPA
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Diflufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Flufenican
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Fluroxypyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Triclopyr
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Clethodim
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Haloxyfop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Fenoxaprop
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Carfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Amicarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Ipfencarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Flucarbazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.


Glufosinate,
Saflufenacil
Sulfentrazone
100:1 to 1:100, preferably
100:1 to 1:100, preferably


salts or esters


1:75 to 75:1, more
1:75 to 75:1, more


thereof or L-


preferably 1:50 to 50:1,
preferably 1:50 to 50:1,


glufosinate,


even more preferably 1:25
even more preferably 1:25


salts or esters


to 25:1, even more
to 25:1, even more


thereof


preferably 1:10 to 10:1 and
preferably 1:10 to 10:1 and





most preferably 1:5 to 5:1.
most preferably 1:5 to 5:1.









In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein glufosinate, salts or esters thereof is present in an amount in the range of 100 to 400 g ai/L, preferably 180 to 380 g ai/L, more preferably 250 to 350 g ai/L. In a preferred embodiment, the formulation comprises 280 g ai/L of glufosinate, salts or esters thereof.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is present in the formulation in an amount in the range of 100 to 400 g ai/L, preferably 140 to 340 g ai/L, more preferably 200 to 250 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is present in the formulation in an amount in the range of 10 to 250 g ai/L, preferably 50-200 g ai/L, more preferably 75-125 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is present in the formulation in an amount in the range of 100 to 1000 g ai/L, preferably 100-800 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is present in the formulation in an amount in the range of 200 to 1000 g ai/L, preferably 400 to 800 g ai/L, more preferably 500-700 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is present in the formulation in an amount in the range of 200-800 g ai/L, preferably 300 to 700 g ai/L, more preferably 400-600 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is present in the formulation in an amount in the range of 200 to 1200 g ai/L, preferably 400-1000 g ai/L, more preferably 450-850 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is present in the formulation in an amount in the range of 400 to 1200 g ai/L, preferably 600-1000 g ai/L, more preferably 750-850 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is present in the formulation in an amount in the range of 300-1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 400 to 750 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is present in the formulation in an amount in the range of 300-1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 500 to 750 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from cyclohexene oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is present in the formulation in an amount in the range of 100-400 g ai/L, preferably 150 to 350 g ai/L, preferably 200-300 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is present in the formulation in an amount in the range of 1 to 250 g ai/L, preferably 10-200 g ai/L and more preferably 50-150 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from triazolone class of herbicides, and wherein the triazolone class of herbicides is present in the formulation in an amount in the range of 100-800 g ai/L, preferably 200 to 600 g ai/L, more preferably 300 to 500 g ai/L.


In an embodiment, the combinations of the present invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is present in the formulation in an amount in the range of 1-1000 g ai/L, preferably 50 to 800 g ai/L.


More surprisingly, it was found that this combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, an herbicide selected from the imidazolinone class of herbicides, and an herbicide selected from the triazolone class of herbicides, acted in a synergistic manner in controlling a range of weeds. The degree of synergistic enhancement in efficacy of the above combination towards control a range of weeds was unpredictable and unexpected.


Therefore, in an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof; a herbicide selected from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the herbicide selected from the imidazolinone class of herbicides is imazethapyr, and wherein the herbicide selected from the triazolone class of herbicides is carfentrazone.


In another embodiment, the present invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazethapyr and carfentrazone, for controlling the growth of undesirable vegetation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazethapyr, and carfentrazone ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazethapyr, and carfentrazone ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.


In an embodiment, the weight ratio of glufosinate, salts or esters thereof, imazethapyr, and carfentrazone ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1, more preferably from 1:2:2 to 2:1:1.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof; an herbicide selected from the phenoxyacetic class of herbicides, and an herbicide selected from the uracil class of herbicides.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the herbicide selected from the phenoxyacetic class of herbicides is 2,4-D, and wherein the herbicide selected from the uracil class of herbicides is saflufenacil.


In another embodiment, the present invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, 2,4-D and saflufenacil, for controlling the growth of undesirable vegetation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, 2,4D, and saflufenacil ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, 2,4-D, and saflufenacil ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.


In an embodiment, the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, 2,4D, and saflufenacil ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof; an herbicide selected from the pyridine class of herbicides, and an herbicide selected from the uracil class of herbicides.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the herbicide selected from the pyridine class of herbicides is triclopyr, and wherein the herbicide selected from the uracil class of herbicides is saflufenacil.


In another embodiment, the present invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, triclopyr and saflufenacil, for controlling the growth of undesirable vegetation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, triclopyr, and saflufenacil ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, triclopyr, and saflufenacil ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.


In an embodiment, the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, triclopyr, and saflufenacil ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1.


in an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof; and two herbicides selected from the imidazolinone class of herbicides.


In an embodiment, the present invention provides a combination for controlling the growth of undesirable vegetation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides of imidazolinones class of herbicides, wherein the two herbicides selected from the imidazolinone class of herbicides are imazapic and imazapyr.


In another embodiment, the present invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazapic and imazapyr, for controlling the growth of undesirable vegetation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazapic, and imazapyr ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazapic, and imazapyr ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.


In an embodiment, the weight ratio of glufosinate, salts or esters thereof, imazapic, and imazapyr ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1.


In an embodiment, the present invention provides a composition comprising the combinations of the present invention along with at least one agrochemically suitable excipient.


In an embodiment, the present invention provides an herbicidal composition comprising glufosinate, salts or esters thereof, at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides;
    • (j) uracil class of herbicides,


      and at least one agrochemically suitable excipient.


In an embodiment, the present invention provides an herbicidal composition comprising L-glufosinate, salts or esters thereof, at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides;
    • (j) uracil class of herbicides,


      and at least one agrochemically suitable excipient.


In an embodiment, the said composition is a tank-mix composition.


In an embodiment, the said composition comprises glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides in a synergistic combination, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and the at least two herbicides is 1:100:100 to 100:1:1, preferably 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1 and even more preferably 1:25:25 to 25:1:1.


In an embodiment, the said composition comprises glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides in a synergistic combination, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and one of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.


In an embodiment, the said composition comprises glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides in a synergistic combination, wherein the weight ratio of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.


In an embodiment, the compositions of the present invention additionally comprise one or more agrochemically suitable excipients such as adjuvants, additives, or carriers along with other ingredients such as surfactants.


The agrochemically suitable excipient may be any one or a combination of adjuvants, co-solvents, surfactants, colorants, dispersants, diluents, emulsifiers, fillers, thickening agents, antifreeze agents, freezing agents, biocides, anti-foaming agents, stabilizers, wetting agents or a mixture thereof which may be optionally added to the compositions of the present invention.


The surfactants may be selected from non-ionic, anionic or cationic surfactants.


Examples of nonionic surfactants include polyarylphenol polyethoxyethers, polyalkylphenol polyethoxy ethers, polyglycol ether derivatives of saturated fatty acids, polyglycol ether derivatives of unsaturated fatty acids, polyglycol ether derivatives of aliphatic alcohols, polyglycol ether derivatives of cycloaliphatic alcohols, fatty acid esters of polyoxyethylene sorbitan, alkoxylated vegetable oils, alkoxylated acetylenic diols, polyalkoxylated alkylphenols, fatty acid alkoxylates, sorbitan alkoxylates, sorbitol esters, C8-C22 alkyl or alkenyl polyglycosides, polyalkoxy styrylaryl ethers, alkylamine oxides, block copolymer ethers, polyalkoxylated fatty glyceride, polyalkylene glycol ethers, linear aliphatic or aromatic polyesters, organo silicones, polyaryl phenols, sorbitol ester alkoxylates, polyalkylene oxide block copolymers, acrylic copolymers and mono- and diesters of ethylene glycol and mixtures thereof.


Examples of anionic surfactants include alcohol sulfates, alcohol ether sulfates, alkylaryl ether sulfates, alkylaryl sulfonates such as alkylbenzene sulfonates and alkylnaphthalene sulfonates and salts thereof, alkyl sulfonates, mono- or di-phosphate esters of polyalkoxylated alkyl alcohols or alkylphenols, mono- or di-sulfosuccinate esters of C12-C15 alkanols or polyalkoxylated C12-C15 alkanols, alcohol ether carboxylates, phenolic ether carboxylates, polybasic acid esters of ethoxylated polyoxyalkylene glycols consisting of oxybutylene or the residue of tetrahydrofuran, sulfoalkylamides and salts thereof such as N-methyl-N-oleoyltaurate Na salt, polyoxyalkylene alkylphenol carboxylates, polyoxyalkylene alcohol carboxylates alkyl polyglycoside/alkenyl succinic anhydride condensation products, alkyl ester sulfates, napthalene sulfonates, naphthalene formaldehyde condensates, alkyl sulfonamides, sulfonated aliphatic polyesters, sulfate esters of styrylphenyl alkoxylates, and sulfonate esters of styrylphenyl alkoxylates and their corresponding sodium, potassium, calcium, magnesium, zinc, ammonium, alkylammonium, diethanolammonium, or triethanolammonium salts, salts of ligninsulfonic acid such as the sodium, potassium, magnesium, calcium or ammonium salt, polyarylphenol polyalkoxyether sulfates and polyarylphenol polyalkoxyether phosphates, and sulfated alkyl phenol ethoxylates and phosphated alkyl phenol ethoxylates.


Cationic surfactants include alkanol amides of C8-C18 fatty acids and C8-C18 fatty amine polyalkoxylates, C10-C18 alkyldimethylbenzylammonium chlorides, coconut alkyldimethylaminoacetic acids, and phosphate esters of C8-C18 fatty amine polyalkoxylates.


Emulsifiers which can be advantageously employed herein can be readily determined by those skilled in the art and include various non-ionic, anionic, cationic and amphoteric emulsifiers, or a blend of two or more emulsifiers. Examples of nonionic emulsifiers useful in preparing the emulsifiable concentrates include the polyalkylene glycol ethers and condensation products of alkyl and aryl phenols, aliphatic alcohols, aliphatic amines or fatty acids with ethylene oxide, propylene oxides such as the ethoxylated alkyl phenols and carboxylic esters solubilized with the polyol or polyoxyalkylene. Cationic emulsifiers include quaternary ammonium compounds and fatty amine salts. Anionic emulsifiers include the oil-soluble salts (e.g., calcium) of alkylaryl sulfonic acids, oil-soluble salts or sulfated polyglycol ethers and appropriate salts of phosphated polyglycol ether.


In an embodiment, colorants may be selected from iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs or metal phthalocyanine dyestuffs, and trace elements, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.


Another embodiment involves addition of a thickening agent or binder which may be selected from but not limited to molasses, granulated sugar, alginates, karaya gum, jaguar gum, tragacanth gum, polysaccharide gum, mucilage, xanthan gum or combination thereof. In another embodiment, the binder may be selected from silicates such as magnesium aluminium silicate, polyvinyl acetates, polyvinyl acetate copolymers, polyvinyl alcohols, polyvinyl alcohol copolymers, celluloses, including ethylcelluloses and methylcelluloses, hydroxymethyl celluloses, hydroxypropylcelluloses, hydroxymethylpropyl-celluloses, polyvinylpyrrolidones, dextrins, malto-dextrins, polysaccharides, fats, oils, proteins, gum arabics, shellacs, vinylidene chloride, vinylidene chloride copolymers, calcium lignosulfonates, acrylic copolymers, starches, polyvinylacrylates, zeins, gelatin, carboxymethylcellulose, chitosan, polyethylene oxide, acrylimide polymers and copolymers, polyhydroxyethyl acrylate, methylacrylimide monomers, alginate, ethylcellulose, polychloroprene and syrups or mixtures thereof; polymers and copolymers of vinyl acetate, methyl cellulose, vinylidene chloride, acrylic, cellulose, polyvinylpyrrolidone and polysaccharide; polymers and copolymers of vinylidene chloride and vinyl acetate-ethylene copolymers; combinations of polyvinyl alcohol and sucrose; plasticizers such as glycerol, propylene glycol and polyglycols.


In another embodiment, antifreeze agent(s) added to the composition may be alcohols selected from the group comprising of but not limited to ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,4-pentanediol, 3-methyl-1,5-pentanediol, 2,3-dimethyl-2,3-butanediol, trimethylol propane, mannitol, sorbitol, glycerol, pentaerythritol, 1,4-cyclohexanedimethanol, xylenol, bisphenols such as bisphenol A or the like. In addition, ether alcohols such as diethylene glycol, triethylene glycol, tetraethylene glycol, polyoxyethylene or polyoxypropylene glycols of molecular weight up to about 4000, diethylene glycol monomethylether, diethylene glycol monoethylether, triethylene glycol monomethylether, butoxyethanol, butylene glycol monobutylether, dipentaerythritol, tripentaerythritol, tetrapentaerythritol, diglycerol, triglycerol, tetraglycerol, pentaglycerol, hexaglycerol, heptaglycerol or octaglycerol may also be used.


According to an embodiment, biocides may be selected from benzothiazoles, 1,2-benzisothiazolin-3-one, sodium dichloro-s-triazinetrione, sodium benzoate, potassium sorbate, 1,2-phenyl-isothiazolin-3-one, inter chloroxylenol paraoxybenzoate butyl.


According to an embodiment, antifoaming agent may be selected from Polydimethoxysiloxane, polydimethylsiloxane, Alkyl poly acrylates, Castor Oil, Fatty Acids, Fatty Acids Esters, Fatty Acids Sulfate, Fatty Alcohol, Fatty Alcohol Esters, Fatty Alcohol Sulfate, Foot Olive Oil, Mono & Di Glyceride, Paraffin Oil, Paraffin Wax, Poly Propylene Glycol, Silicones Oil, Vegetable & Animal Fats, Vegetable & Animal Fats Sulfate, Vegetable & Animal Oil, Vegetable & Animal Oil Sulfate, Vegetable & Animal Wax, Vegetable & Animal Wax Sulfate, agents based on silicon or magnesium stearate.


Representative organic liquids which can be employed in preparing the emulsifiable concentrates of the present invention are the aromatic liquids such as xylene, propyl benzene fractions, or mixed naphthalene fractions, mineral oils, substituted aromatic organic liquids such as dioctyl phthalate, kerosene, dialkyl amides of various fatty acids, particularly the dimethyl amides of fatty glycols and glycol derivatives such as the n-butyl ether, ethyl ether or methyl ether of diethylene glycol, and the methyl ether of triethylene glycol. Mixtures of two or more organic liquids are also often suitably employed in the preparation of the emulsifiable concentrate. The formulations can also contain other compatible additives, for example, plant growth regulators and other biologically active compounds used in agriculture.


The additives to be used for the formulation include, for example, a solid carrier such as kaolinite, sericite, diatomaceous earth, slaked lime, calcium carbonate, talc, white carbon, kaoline, bentonite, clay, sodium carbonate, sodium bicarbonate, mirabilite, zeolite or starch; a solvent such as water, toluene, xylene, solvent naphtha, dioxane, dimethylsulfoxide, N,N-dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone or an alcohol; an anionic surfactant such as a salt of fatty acid, a benzoate, a polycarboxylate, a salt of alkylsulfuric acid ester, an alkyl sulfate, an alkylaryl sulfate, an alkyl diglycol ether sulfate, a salt of alcohol sulfuric acid ester, an alkyl sulfonate, an alkylaryl sulfonate, an aryl sulfonate, a lignin sulfonate, an alkyldiphenylether disulfonate, a polystyrene sulfonate, a salt of alkylphosphoric acid ester, an alkylaryl phosphate, a styrylaryl phosphate, a salt of polyoxyethylene alkyl ether sulfuric acid ester, a polyoxyethylene alkylaryl ether sulfate, a salt of polyoxyethylene alkylaryl ether sulfuric acid ester, a polyoxyethylene alkyl ether phosphate, a salt of polyoxyethylene alkylaryl phosphoric acid ester, a salt of polyoxyethylene aryl ether phosphoric acid ester, a naphthalene sulfonic acid condensed with formaldehyde or a salt of alkylnaphthalene sulfonic acid condensed with formaldehyde; a nonionic surfactant such as a sorbitan fatty acid ester, a glycerin fatty acid ester, a fatty acid polyglyceride, a fatty acid alcohol polyglycol ether, acetylene glycol, acetylene alcohol, an oxyalkylene block polymer, a polyoxyethylene alkyl ether, a polyoxyethylene alkylaryl ether, a polyoxyethylene styrylaryl ether, a polyoxyethylene glycol alkyl ether, polyethylene glycol, a polyoxyethylene fatty acid ester, a polyoxyethylene sorbitan fatty acid ester, a polyoxyethylene glycerin fatty acid ester, a polyoxyethylene hydrogenated castor oil or a polyoxypropylene fatty acid ester; and a vegetable oil or mineral oil such as olive oil, kapok oil, castor oil, palm oil, camellia oil, coconut oil, sesame oil, corn oil, rice bran oil, peanut oil, cottonseed oil, soybean oil, rapeseed oil, linseed oil, tung oil or liquid paraffins. These additives may suitably be selected for use alone or in combination as a mixture of two or more of them, so long as the object of the present invention is met. Further, additives other than the above-mentioned may be suitably selected for use among those known in this field. For example, various additives commonly used, such as a filler, a thickener, an anti-settling agent, an anti-freezing agent, a dispersion stabilizer, a safener, an anti-mold agent, a bubble agent, a disintegrator and a binder, may be used.


The agrochemical formulation may also comprise one or more antioxidants. Preferably, the agrochemical formulation comprises an antioxidants. Antioxidants are, for example, amino acids (e.g. Glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazole and imidazole derivatives (e.g. urocanic acid), peptides, such as, for example, D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine), carotenoids, carotenes (e.g. α-carotene, β-carotene, lycopene) and derivatives thereof, lipoic acid and derivatives thereof (e.g. dihydrolipoic acid), aurothioglucose, propylthiouracil and further thio compounds (e.g. thioglycerol, thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl, lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters thereof), and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), and sulfoximine compounds (e.g. buthionine sulfoximines, homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very low tolerated doses (e.g. pmol/kg to pmol/kg), also metal chelating agents (e.g. α-hydroxy fatty acids, EDTA, EGTA, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acids, bile acid, bile extracts, gallic esters (e.g. propyl, octyl and dodecyl gallate), flavonoids, catechins, bilirubin, biliverdin and derivatives thereof, unsaturated fatty acids and derivatives thereof (e.g. γ-linolenic acid, linoleic acid, arachidonic acid, oleic acid), folic acid and derivatives thereof, hydroquinone and derivatives thereof (e.g. arbutin), ubiquinone and ubiquinol, and derivatives thereof, vitamin C and derivatives thereof (e.g. ascorbyl palmitate, stearate, dipalmitate, acetate, Mg ascorbyl phosphates, sodium and magnesium ascorbate, disodium ascorbyl phosphate and sulfate, potassium ascorbyl tocopheryl phosphate, chitosan ascorbate), isoascorbic acid and derivatives thereof, tocopherols and derivatives thereof (e.g. tocopheryl acetate, linoleate, oleate and succinate, tocophereth-5, tocophereth-10, tocophereth-12, tocophereth-18, tocophereth-50, tocophersolan), vitamin A and derivatives (e.g. vitamin A palmitate), the coniferyl benzoate of benzoin resin, rutin, rutinic acid and derivatives thereof, disodium rutinyl disulfate, cinnamic acid and derivatives thereof (e.g. ferulic acid, ethyl ferulate, caffeeic acid), kojic acid, chitosan glycolate and salicylate, butylhydroxytoluene, butylhydroxyanisol, nordihydroguaiacic acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, selenium and selenium derivatives (e.g. selenomethionine), stilbenes and stilbene derivatives (e.g. stilbene oxide, trans-stilbene oxide). According to the invention, suitable derivatives (salts, esters, sugars, nucleotides, nucleosides, peptides and lipids) and mixtures of these specified active ingredients or plant extracts (e.g. teatree oil, rosemary extract and rosemarinic acid) which comprise these antioxidants can be used. In general, mixtures of the aforementioned antioxidants are possible.


According to an embodiment, examples of suitable solvents are water, aromatic solvents (for example Solvesso products, xylene), paraffins (for example mineral oil fractions such as kerosene or diesel oil), coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, for example toluene, xylene, paraffin, tetrahydronaphthalene, alkylated naphthalenes or their derivatives, alcohols (for example methanol, butanol, pentanol, benzyl alcohol, cyclohexanol), ketones (for example cyclohexanone, gamma-butyrolactone), pyrrolidones (NMP, NEP, NOP), acetates (glycol diacetate), glycols, fatty acid dimethylamides, fatty acids and fatty acid esters, isophorone and dimethylsulfoxide. In principle, solvent mixtures may also be used.


According to an embodiment, suitable surfactants are alkali metal, alkaline earth metal and ammonium salts of lignosulfonic acid, naphthalenesulfonates, phenolsulfonic acid, dibutylnaphthalenesulfonic acid, alkylarylsulfonates, alkyl sulfates, alkylsulfonates, fatty alcohol sulfates, fatty acids and sulfated fatty alcohol glycol ethers, furthermore condensates of sulfonated naphthalene and naphthalene derivatives with formaldehyde, condensates of naphthalene or of naphthalenesulfonic acid with phenol and formaldehyde, polyoxyethylene octylphenol ethers, ethoxylated isooctylphenol, octylphenol, nonylphenol, alkylphenol polyglycol ethers, tributylphenyl polyglycol ethers, tristearylphenyl polyglycol ethers, alkylaryl polyether alcohols, alcohol and fatty alcohol/ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl ethers, ethoxylated polyoxypropylene, lauryl alcohol polyglycol ether acetal, sorbitol esters, lignosulfite waste liquors and methylcellulose.


According to an embodiment, examples of suitable carriers are mineral earths such as silica gels, silicates, talc, kaolin, attaclay, attapulgite, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate, magnesium sulfate, magnesium oxide, ground synthetic materials, fertilizers, such as, for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders, polyvinylpyrrolidone and other solid carriers).


Suitable preservatives are for example 1,2-benzisothiazolin-3-one and/or 2-Methyl-2H-isothiazol-3-one or sodium benzoate or benzoic acid.


In an embodiment, the composition may be in any agriculturally suitable form for storage and application to the ground. The compositions of the present invention may typically be produced by mixing the actives in the composition with an inert carrier, and adding surfactants and other adjuvants and carriers as needed and formulated into solid, or liquid formulations, including but not limited to powders, wettable powders, pellets, tablets, granules, dusts, dry flowables, water-dispersible granules, microcapsules, soluble (liquid) concentrates, suspension concentrates, oil in water emulsion, water in oil emulsion, emulsifiable concentrates, capsule suspensions, ZC formulations, oil dispersions or other known formulation types.


The terms “g ai/L” as used herein denotes the concentration of the respective active ingredient in “grams” present “per litre” of the composition.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein glufosinate, salts or esters thereof is present in an amount in the range of 100 to 400 g ai/L, preferably 180 to 380 g ai/L, more preferably 250 to 350 g ai/L. In a preferred embodiment, the formulation comprises 280 g ai/L of glufosinate, salts or esters thereof.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is present in the formulation in an amount in the range of 100 to 400 g ai/L, preferably 140 to 340 g ai/L, more preferably 200 to 250 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is present in the formulation in an amount in the range of 10 to 250 g ai/L, preferably 50-200 g ai/L, more preferably 75-125 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is present in the formulation in an amount in the range of 100 to 1000 g ai/L, preferably 100-800 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is present in the formulation in an amount in the range of 200 to 1000 g ai/L, preferably 400 to 800 g ai/L, more preferably 500-700 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is present in the formulation in an amount in the range of 200-800 g ai/L, preferably 300 to 700 g ai/L, more preferably 400-600 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is present in the formulation in an amount in the range of 200 to 1200 g ai/L, preferably 400-1000 g ai/L, more preferably 450-850 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is present in the formulation in an amount in the range of 400 to 1200 g ai/L, preferably 600-1000 g ai/L, more preferably 750-850 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is present in the formulation in an amount in the range of 300-1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 400 to 750 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is present in the formulation in an amount in the range of 300-1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 500 to 750 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from cyclohexene oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is present in the formulation in an amount in the range of 100-400 g ai/L, preferably 150 to 350 g ai/L, preferably 200-300 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is present in the formulation in an amount in the range of 1 to 250 g ai/L, preferably 10-200 g ai/L and more preferably 50-150 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from triazolone class of herbicides, and wherein the triazolone class of herbicides is present in the formulation in an amount in the range of 100-800 g ai/L, preferably 200 to 600 g ai/L, more preferably 300 to 500 g ai/L.


In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is present in the formulation in an amount in the range of 1-1000 g ai/L, preferably 50 to 800 g ai/L.


The composition may also be used for treatment of a plant propagation material such as seeds etc.


The compositions of the present invention may be applied in any known ways or conventional methods known to a person skilled in art. Non-limiting examples of such methods are foliar spray, basal barking, stem injection, drill and fill method, axe cut method, cut stump, cut and swab, stem scraper, wick application and so forth. The compositions of the present invention are used in the customary manner, for example by watering, spraying, atomizing, dusting or scattering. Said compositions can be applied to a locus by the use of conventional ground sprayers, granule applicators, watering (drenching), drip irrigation, spraying, atomizing, broadcasting, dusting, foaming, spreading-on, aerial methods of spraying, aerial methods of application, methods utilizing application using modern technologies such as, but not limited to, drones, robots and by other conventional means known to those skilled in the art.


In an embodiment, the present invention provides a method of controlling the growth of undesirable vegetation, the method comprising treating the locus at which control is desired with combinations or synergistic combinations of the present invention or compositions comprising said combinations.


In an embodiment, the present invention provides a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with an herbicidal combination or a composition comprising said combination, wherein the combination comprises glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • a) nitrophenyl ether class of herbicides;
    • b) imidazolinone class of herbicides;
    • c) organophosphorous class of herbicides;
    • d) dicarboximide class of herbicides;
    • e) phenoxyacetic class of herbicides;
    • f) pyridine class of herbicides;
    • g) cyclohexene oxime class of herbicides;
    • h) aryloxyphenoxypropionic class of herbicides;
    • i) triazolone class of herbicides; and/or
    • j) uracil class of herbicides.


In an embodiment, the present invention provides a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with an herbicidal combination or a composition comprising said combination, wherein the combination comprises comprising L-glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • a) nitrophenyl ether class of herbicides;
    • b) imidazolinone class of herbicides;
    • c) organophosphorous class of herbicides;
    • d) dicarboximide class of herbicides;
    • e) phenoxyacetic class of herbicides;
    • f) pyridine class of herbicides;
    • g) cyclohexene oxime class of herbicides;
    • h) aryloxyphenoxypropionic class of herbicides;
    • i) triazolone class of herbicides; and/or
    • j) uracil class of herbicides.


In an embodiment, the present invention provides a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic herbicidal combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • k) nitrophenyl ether class of herbicides;
    • l) imidazolinone class of herbicides;
    • m) organophosphorous class of herbicides;
    • n) dicarboximide class of herbicides;
    • o) phenoxyacetic class of herbicides;
    • p) pyridine class of herbicides;
    • q) cyclohexene oxime class of herbicides;
    • r) aryloxyphenoxypropionic class of herbicides;
    • s) triazolone class of herbicides;
    • t) uracil class of herbicides,
    • or combinations thereof.


In an embodiment, the present invention provides a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic herbicidal combination comprising L-glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • k) nitrophenyl ether class of herbicides;
    • l) imidazolinone class of herbicides;
    • m) organophosphorous class of herbicides;
    • n) dicarboximide class of herbicides;
    • o) phenoxyacetic class of herbicides;
    • p) pyridine class of herbicides;
    • q) cyclohexene oxime class of herbicides;
    • r) aryloxyphenoxypropionic class of herbicides;
    • s) triazolone class of herbicides;
    • t) uracil class of herbicides,
    • or combinations thereof.


In an embodiment, the present invention provides a method for increasing yield in a crop by using the combinations of the present invention. Therefore, in an embodiment, the present invention provides a method for increasing yield in a crop by application of a combination or composition comprising—glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides.


In an embodiment, the present invention provides a method for improving the plant health using the combinations of the present invention. Therefore, in an embodiment, the present invention provides a method for improving the plant health by application of a combination or composition comprising—glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides selected from:

    • (a) nitrophenyl ether class of herbicides;
    • (b) imidazolinone class of herbicides;
    • (c) organophosphorous class of herbicides;
    • (d) dicarboximide class of herbicides;
    • (e) phenoxyacetic class of herbicides;
    • (f) pyridine class of herbicides;
    • (g) cyclohexene oxime class of herbicides;
    • (h) aryloxyphenoxypropionic class of herbicides;
    • (i) triazolone class of herbicides; and/or
    • (j) uracil class of herbicides


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and the at least two herbicides is 1:100:100 to 100:1:1, preferably 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1 and even more preferably 1:25:25 to 25:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and one of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the weight ratio of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides, wherein glufosinate, salts or esters thereof, the herbicide selected from the imidazolinone class of herbicides, and the herbicide selected from the triazolone class of herbicides are present in a ratio of 1:100:100 to 100:1:1, more preferably 1:10:10 to 10:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; a herbicide selected from the imidazolinone class of herbicides; and a herbicide selected from the triazolone class of herbicides, wherein the imidazolinone class herbicide is imazethapyr and the triazolone class herbicide is carfentrazone.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, imazethapyr and carfentrazone, wherein the weight ratio of glufosinate, salts or esters thereof, imazethapyr and carfentrazone is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1, more preferably 1:2:2 to 2:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the phenoxyacetic class of herbicides, and a herbicide selected from the uracil class of herbicides.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the phenoxyacetic class of herbicides, and a herbicide selected from the uracil class of herbicides, wherein glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, the herbicide selected from the phenoxyacetic class of herbicides, and the herbicide selected from the uracil class of herbicides are present in a ratio of 1:100:100 to 100:1:1, more preferably 1:10:10 to 10:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; a herbicide selected from the phenoxyacetic class of herbicides; and a herbicide selected from the uracil class of herbicides, wherein the phenoxyacetic class herbicide is 2,4-D and the uracil class herbicide is saflufenacil.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, 2,4-D and saflufenacil, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, 2,4-D and saflufenacil is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the pyridine class of herbicides, and a herbicide selected from the uracil class of herbicides.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the pyridine class of herbicides, and a herbicide selected from the uracil class of herbicides, wherein glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, the herbicide selected from the pyridine class of herbicides, and the herbicide selected from the uracil class of herbicides are present in a ratio of 1:100:100 to 100:1:1, more preferably 1:10:10 to 10:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; a herbicide selected from the pyridine class of herbicides; and a herbicide selected from the uracil class of herbicides, wherein the pyridine class herbicide is triclopyr and the uracil class herbicide is saflufenacil.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, triclopyr and saflufenacil, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, triclopyr and saflufenacil is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and two herbicides selected from the imidazolinone class of herbicides.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and two herbicides selected from the imidazolinone class of herbicides, wherein glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof and the two herbicides selected from the imidazolinone class of herbicides are present in a ratio of 1:100:100 to 100:1:1, more preferably 1:10:10 to 10:1:1.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; and two herbicides selected from the imidazolinone class of herbicides; wherein the imidazolinone class herbicides are imazapic and imazapyr.


In an embodiment, the present invention provides for a method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, imazapic and imazapyr, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, imazapic and imazapyr is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1.


The terms “g ai/h” as used herein denotes the concentration of the respective active ingredient in “grams” applied “per hectare” of the crop field.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the combination or composition comprises glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, in an amount in the range of 100 to 400 g ai/L, preferably 180 to 380 g ai/L, more preferably 250 to 350 g ai/L. In a preferred embodiment, the composition comprises 280 g ai/L of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof and at least two herbicides or a composition comprising said combination, wherein glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof is applied at an application rate of 50-350 g ai/h, preferably 100 g ai/h to 250 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is present in the composition in an amount in the range of 100 to 400 g ai/L, preferably 140 to 340 g ai/L, more preferably 200 to 250 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is applied at an application rate of 5-250 g ai/h, preferably at a rate of 50-150 g ai/h and more preferably at a rate of 75-125 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is present in the composition in an amount in the range of 10 to 250 g ai/L, preferably 50-200 g ai/L, more preferably 75-125 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is present in the composition in an amount in the range of 100 to 1000 g ai/L, preferably 100-800 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is applied at an application rate of 5-200 g ai/h, preferably at a rate of 10 to 150 g ai/h and more preferably at a rate of 10-100 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is present in the composition in an amount in the range of 200 to 1000 g ai/L, preferably 400 to 800 g ai/L, more preferably 500-700 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is applied at an application rate of 100-800 g ai/h, preferably at a rate of 200-500 g ai/h, more preferably 300-400 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is present in the composition in an amount in the range of 200-800 g ai/L, preferably 300 to 700 g ai/L, more preferably 400-600 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is applied at an application rate of 1 to 200 g ai/h, preferably 5-100 g ai/h, more preferably at a rate of 10-50 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is present in the composition in an amount in the range of 200 to 1200 g ai/L, preferably 400-1000 g ai/L, more preferably 450-850 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is present in the composition in an amount in the range of 400 to 1200 g ai/L, preferably 600-1000 g ai/L, more preferably 750-850 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is applied at an application rate of 50-400 g ai/h, preferably 100-300 g ai/h, more preferably at a rate of 150-250 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is present in the composition in an amount in the range of 300-1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 400 to 750 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is present in the composition in an amount in the range of 300-1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 500 to 750 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is applied at an application rate of 50-500 g ai/h, preferably at a rate of 100-400 g ai/h and more preferably 200-350 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from cyclohexene oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is present in the composition in an amount in the range of 100-400 g ai/L, preferably 150 to 350 g ai/L, more preferably 200-300 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from cyclohexene oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is applied at an application rate of 1-150 g ai/h, preferably at a rate of 10-100 g ai/h, more preferably 25-75 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is present in the composition in an amount in the range of 1 to 250 g ai/L, preferably 10-200 g ai/L and more preferably 50-150 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is applied at an application rate of 1-150 g ai/h, preferably at a rate of 10-100 g ai/h, more preferably 25-75 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from triazolone class of herbicides, and wherein the triazolone class of herbicides is present in the composition in an amount in the range of 100-800 g ai/L, preferably 200 to 600 g ai/L, more preferably 300 to 500 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from triazolone class of herbicides, and wherein the triazolone class of herbicides is applied at an application rate of 0.5-100 g ai/h, preferably at a rate of 1-50 g ai/h, more preferably 2-30 g ai/h.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is present in the composition in an amount in the range of 1-1000 g ai/L, preferably 50 to 800 g ai/L.


In an embodiment, the present invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is applied at an application rate of 10-150 g ai/h, preferably at a rate of 20-70 g ai/h.


The compositions of the present invention can be used in agricultural lands such as fields, paddy fields, lawns and orchards or in non-agricultural lands. The present invention may be used to control diseases in agricultural lands for cultivating the plants without any phytotoxicity to the plant. Examples of the crops on which the present compositions may be used include but are not limited to corn, rice, wheat, barley, rye, oat, Sorghum, cotton, soybean, peanut, buckwheat, beet, rapeseed, sunflower, sugar cane, tobacco, etc.; vegetables: solanaceous vegetables such as eggplant, tomato, pimento, pepper, potato, etc., cucurbit vegetables such as cucumber, pumpkin, zucchini, water melon, melon, squash, etc., cruciferous vegetables such as radish, white turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, leaf mustard, broccoli, cauliflower, etc., asteraceous vegetables such as burdock, crown daisy, artichoke, lettuce, etc, liliaceous vegetables such as green onion, onion, garlic, and asparagus, ammiaceous vegetables such as carrot, parsley, celery, parsnip, etc., chenopodiaceous vegetables such as spinach, Swiss chard, etc., lamiaceous vegetables such as Perilla frutescens, mint, basil, etc, strawberry, sweet potato, Dioscorea japonica, colocasia, etc., flowers, foliage plants, turf grasses, fruits: pome fruits such apple, pear, quince, etc, stone fleshy fruits such as peach, plum, nectarine, Prunus mume, cherry fruit, apricot, prune, etc., citrus fruits such as orange, lemon, rime, grapefruit, etc., nuts such as chestnuts, walnuts, hazelnuts, almond, pistachio, cashew nuts, macadamia nuts, etc. berries such as blueberry, cranberry, blackberry, raspberry, etc., grape, kaki fruit, olive, plum, banana, coffee, date palm, coconuts, etc., trees other than fruit trees; tea, mulberry, flowering plant, trees such as ash, birch, dogwood, Eucalyptus, Ginkgo biloba, lilac, maple, Quercus, poplar, Judas tree, Liquidambar formosana, plane tree, Zelkova, Japanese arborvitae, fir wood, hemlock, juniper, Pinus, Picea, and Taxus cuspidate, etc.


In an embodiment, the combinations or the compositions of the present invention may be used for controlling a wide range of weeds such as Glycine max, Borreria verticillate, Eleusine indica, Amaranthus viridus, Lolium spp, Euphorbia heterophylla, Spermacoce verticillate, Spermacoce latifolia, and Brachiaria decumbens.


Examples of weeds controlled by the composition of the invention include, but are not limited to: Annual mercury, Black bindweed, Black medick, Black nightshade, Canadian fleabane, Charlock, Cleavers, Common amaranth, Common chickweed, Common fiddleneck, Common field-speedwell, Common fumitory, Common hemp-nettle, Common orache, Common poppy, Corn chamomile, Corn marigold, Corn spurrey, Cut-leaved crane's-bill, Dove's-foot crane's-bill, Dwarf spurge, Fat-hen, Field forget-me-not, Field Madder, Field pansy, Field penny-cress, Flixweed, Fool's parsley, Gallant soldiers, Garlic mustard, Groundsel, Hairy bittercress, Hairy Tare, Hedge mustard, Henbit dead-nettle, Himalayan balsam, Ivy-leaved speedwell, Knotgrass, Lesser trefoil, Long-headed poppy, Nipplewort, Oxford ragwort, Pale persicaria, Parsley piert, Petty spurge, Pineappleweed, Prickly lettuce, Prickly sow-thistle, Red dead-nettle, Redshank, Scarlet pimpernel, Scented mayweed, Scentless mayweed, Shepherd's purse, Small nettle, Smooth hawk's-beard, Smooth sow-thistle, Spear-leaved orache, Sticky mouse-ear, Stinking chamomile, Sun spurge, Swine cress, Thale cress, Thorn-apple, Wall speedwell, Wild radish, Annual meadow-grass, Barren brome, Black-grass, Soft brome, Wall Barley, Wild-oat, Winter wild-oat, Caper spurge, Evening-primrose, Giant hogweed, Goat's-beard, Hemlock, Hogweed, Spear thistle, Bracken, Field horsetail, Rushes, Bramble, Broad-leaved dock, Bulbous buttercup, Cat's-ear, Coltsfoot, Common mouse-ear, Common nettle, Common ragwort, Common sorrel, Common toadflax, Cow parsley, Creeping buttercup, Creeping thistle, Curled dock, Daisy, Dandelion, Field bindweed, Greater plantain, Ground elder, Ground-ivy, Hedge bindweed, Hoary cress, Japanese knotweed, Lesser celandine, Meadow buttercup, Mouse-ear-hawkweed, Mugwort, Perennial sowthistle, Perforate St John, Procumbent pearlwort, Ribwort plantain, Rosebay willowherb, Selfheal, Sheep's sorrel, Slender speedwell, Thyme-leaved speedwell, White campion, White clover, Yarrow, Black bent, Cock's-foot, Common bent, Common couch, Creeping bent, Creeping soft-grass, Onion couch, Perennial rye-grass, Rough meadow-grass, Yorkshire fog, Volunteer cereals, Volunteer oilseed rape, Volunteer Potato, Weed Beet, Alopecurus myosuroides Huds. (blackgrass, ALOMY), Amaranthus palmeri (Palmer amaranth, AMAPA) Amaranthus viridis (slender amaranth, AMAVI), Avena fatua (wild oat, AVEFA), Brachiaria decumbens Stapf. or Urochloa decumbens (Stapf), Brachiaria brizantha or Urochloa brizantha, Brachiaria platyphylla (Groseb.) Nash or Urochloa platyphylla (broadleaf signalgrass, BRAPP), Brachiaria plantaginea. or Urochloa plantaginea (alexandergrass, BRAPL), Cenchrus echinatus (southern sandbur, CENEC), Digitaria horizontalis Willd. (Jamaican crabgrass, DIGHO), Digitaria insularis (sourgrass, TRCIN), Digitaria sanguinalis (large crabgrass, DIGSA), Echinochloa crus-galli (barnyardgrass, ECHCG), Echinochloa colonum (junglerice, ECHCO), Eleusine indica Gaertn. (goosegrass, ELEIN), Lolium multiflorum Lam. (Italian ryegrass, LOLMU), Panicum dichotomiflorum Michx. (fall Panicum, PANDI), Panicum miliaceum L. (wild-proso millet, PANMI), Sesbania exaltata (hemp Sesbania, SEBEX), Setaria faberi Herrm. (giant foxtail, SETFA), Setaria viridis (green foxtail, SETVI), Sorghum halepense (Johnsongrass, SORHA), Sorghum bicolor, Moench ssp., Arundinaceum (shattercane, SORVU), Cyperus esculentus (yellow nutsedge, CYPES), Cyperus rotundus (purple nutsedge, CYPRO), Abutilon theophrasti (velvetleaf, ABUTH), Amaranthus species (pigweeds and amaranths, AMASS), Ambrosia artemisiifolia L. (common ragweed, AMBEL), Ambrosia psilostachya DC. (western ragweed, AMBPS), Ambrosia trifida (giant ragweed, AMBTR), Anoda cristata (spurred Anoda, ANVCR), Asclepias syriaca (common milkweed, ASCSY), Bidens pilosa (hairy beggarticks, BIDPI), Borreria species (BOISS), Borreria alata or Spermacoce alata Aubl. or Spermacoce latifolia (broadleaf buttonweed, BOILF), Chenopodium album L. (common lambsquarters, CHEAL), Cirsium arvense (Canada thistle, CIRAR), Commelina benghalensis (tropical spiderwort, COMBE), Datura stramonium (jimsonweed, DATST), Daucus carota (wild carrot, DAUCA), Euphorbia heterophylla (wild poinsettia, EPHHL), Euphorbia hirta or Chamaesyce hirta (garden spurge, EPHHI), Euphorbia dentata Michx. (toothed spurge, EPHDE), Erigeron bonariensis or Conyza bonariensis (hairy fleabane, ERIBO), Erigeron canadensis or Conyza canadensis (horseweed, ERICA), Conyza sumatrensis (tall fleabane, ERIFL), Helianthus annuus (common sunflower, HELAN), Jacquemontia tamnifolia (smallflower morningglory, IAQTA), Ipomoea hederacea (ivyleaf morningglory, IPOHE), Ipomoea lacunosa (white morningglory, IPOLA), Lactuca serriola (prickly lettuce, LACSE), Portulaca oleracea (common purslane, POROL), Richardia species (pusley, RCHSS), Salsola tragus (Russian thistle, SASKR), Sida species (Sida, SIDSS), Sida spinosa (prickly Sida, SIDSP), Sinapis arvensis (wild mustard, SINAR), Solanum ptychanthum (eastern black nightshade, SOLPT), Tridax procumbens (coat buttons, TRQPR), Rumex dentatus (RUMDE) or Xanthium strumarium (common cocklebur, XANST), crabgrass complex (Digitaria horizontalis, Digitaria nuda and others), guinea grass (Panicum maximum), Surinam grass (Brachiaria decumbens), morning glories (Ipomoea grandifolia, Ipomoea nil, Ipomoea quamoclit, Ipomoea purpurea, Ipomoea hederifolia, Merremia cissoides and Merremia aegypta), beggar-ticks (Bidens pilosa), Java grass or purple nut sedge (Cyperus rotundus and Cyperus spp), Indian goosegrass or crowfoot grass (Eleusine indica), southern sandbur (Cenchrus echinatus), velvet bean or Mucuna (Mucuna pruriens), wild poinsettia or milkweed (Euphorbia heterophylla), Paraguayan starbur (Acanthospermum australe), Slender amaranth (Amaranthus viridis), Alexandergrass (Brachiaria plantaginea), Benghal dayflower (Commelina benghalensis), Lilac tasselflower (Emilia sonchifolia), Wild poinsettia or milkweed (Euphorbia heterophylla), Gallant soldier (Galinsoga parviflora), Purslane or pigweed (Portulaca oleracea), Brazilian calla-lily or Brazil pusley (Richardia brasiliensis), Flannel weed (Sida cordifolia), Southern Sida (Sida glaziovii), Southern Sida (Sida rhombifolia), Buttonweed or broad-leaved buttonweed (Spermacoce latifólia).


In a preferred embodiment, the weeds controlled by the combinations/compositions of the present invention include weedy Glycine max, Spermacoce latifolia, Eleusine indica and Brachiaria decumbens.


In a preferred embodiment, the weeds controlled by the combinations/compositions of the present invention include Borreria verticillata, Euphorbia heterophylla, Lolium spp., and Amaranthus spp.


The combinations of the present invention may be sold as a pre-mix composition or a kit of parts such that individual actives may be mixed before spraying. Alternatively, the kit of parts may contain the at least two herbicides pre-mixed and the glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, packaged separately, such that the components may be tank mixed before spraying.


The method of control of the present invention may be carried out by spraying the suggested tank mixes, or the individual herbicides may be formulated as a kit-of-parts containing various components that may be mixed as instructed prior to spraying.


In an embodiment, the present invention provides a kit-of-parts comprising a plurality of components, wherein said plurality of components comprises:

    • a) a first component as glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof;
    • b) a second component comprising a herbicide selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone, or uracil class of herbicides; and
    • c) a third component comprising a herbicide selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone, or uracil class of herbicides.


In an embodiment, the kit-of-parts comprises an instructions manual, said instructions manual comprising instructions directing a user to admix the components before being used.


In an embodiment, each of the components of the present invention may be packaged separately and may be tank mixed at the time of spraying.


In another embodiment, the components of the present invention may be packaged as composition such that the glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and the at least two herbicides are formulated into one composition and other additives are packaged separately, such that the two maybe tank mixed at the time of spraying.


Surprisingly, it has been found by the present inventors, that when glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and the at least two herbicides of the present invention, when applied individually, was ineffective in the control of weeds, but demonstrated excellent synergistic control on when applied together. The current invention therefore provides advantageous combinations, compositions and methods of controlling weeds.


The combinations of the present invention or compositions comprising the said combinations maybe applied simultaneously as a tank mix or a formulation or may be applied sequentially. The combinations may be a tank mixes of compositions of individual active ingredients. The application may be made as a foliar spray at different timings during crop development, with either one or two applications early or late post-emergence.


The present invention is more particularly described in the following examples that are intended as illustration only, since numerous modifications and variations within the scope of the present invention will be apparent to those of skill in the art. Unless otherwise noted, all parts, percentages, and ratios reported in the following examples are on a weight basis, and all reagents used in the examples were obtained or are available from the chemical suppliers.


The following examples illustrates the composition, underlying effect and basic methodology of the present invention.


Examples

The following examples demonstrate the present invention.


Composition:

A combination of L-glufosinate, Imazethapyr and carfentrazone was prepared with the following dosage of active ingredients (a.i.)
















Active ingredient
Amount a.i., g/L









L-glufosinate
280



Imazethapyr
106



Carfentrazone
400










A combination of L-glufosinate, triclopyr and safluenacil was prepared with the following dosage of active ingredients (a.i.)
















Active ingredient
Amount a.i., g/L









L-glufosinate
280



Triclopyr
480



Saflufenacil
700










A combination of L-glufosinate, 2,4D and saflufenacil was prepared with the following dosage of active ingredients (a.i.)
















Active ingredient
Amount a.i., g/L









L-glufosinate
280



2,4D
456



Saflufenacil
700










A combination of L-glufosinate, imazapic and imazapyr was prepared with the following dosage of active ingredients (a.i.)
















Active ingredient
Amount a.i., g/L









L-glufosinate
280



Imazapic + imazapyr
525 + 175










Evaluation of Post-Emergence Herbicidal Activity of Combinations Under Field Conditions

Methodology: Greenhouse trials were carried out to evaluate the efficacy of the combination of L-glufosinate and the other herbicides on weeds such as Glycine max, Spermacoce verticilata, Eleusine indica, Brachiaria decumbens. The soil used was sandy clay loam—Sand: 68.0%; Silt: 8.0%; Clay: 24.0%. All treatments were conducted in 4 replications per treatment with a spray volume of 150 L/h.


Evaluation

The expected efficacy of a combination of L-glufosinate and the other herbicides was calculated using the well-established Colby method. Any difference between the observed and “expected” efficacy could be attributed to synergy between the two compounds.


In the Colby method, the expected (or predicted) response of a combination of herbicides is calculated by taking the product of the observed response for each individual component of the combination when applied alone, divided by 100, and subtracting this value from the sum of the observed response for each component when applied alone. An unexpected enhancement in efficacy of the combination is then determined by comparing the observed response of the combination to the expected (or predicted) response as calculated from the observed response of each individual component alone. If the observed response of the combination is greater than the expected (or predicted) response, or stated conversely, if the difference between the observed and expected response is greater than zero, then the combination is said to be synergistic or unexpectedly effective (Colby, S. R., Weeds, 1967(15), p. 20-22). The Colby method requires only a single dose of each herbicide applied alone and the mixture of both doses. The formula used to calculate the expected efficacy (EE) which was compared with the observed efficacy (OE) to determine the efficacy of the present invention is explained hereinbelow:


The expected efficacy for a combination of two active ingredients is as follows:






EE
=

(

A
+
B
-


(

A
×
B

)

/
100


)





The expected efficacy for a combination of three active ingredients is as follows:






EE
=

A
+
B
+
C
-


(

AB
+
AC
+
BC

)

/
100

+

ABC
/
10
,
000






Where,

    • A=Observed efficacy of active ingredient A at the same concentration as used in the mixture.
    • B=Observed efficacy of the active ingredient B at the same concentration as used in the mixture.
    • C=Observed efficacy of the active ingredient C at the same concentration as used in the mixture.









TABLE 3







Table 3 demonstrates synergy on weeds using the combination of L-glufosinate,


imazethapyr and carfentrazone. The percentage efficacy was calculated for 14, 21, 28, 35 days


of applications (DAA). The target weed was weedy Glycine max, and the concentration of the


herbicide and the results are recorded the table 3 below:















Active



















ingredient, dose
14 DAA
21 DAA
28 DAA
35 DAA















a.i., g/h
Control %
Colby*
Control %
Colby*
Control %
Colby*
Control %
Colby*


















L-glufosinate,
60

63.3

63.3

52.7



150










Imazethapyr, 75.0
10

20.0

20.0

15.0



Carfentrazone,
50.3

44.3

44.3

39.3



7.5










L-glufosinate,
89.3
82.1
95.3
83.6
96.7
83.6
96.0
75.6


150 +










imazethapyr, 75 +










carfentrazone, 7.5





*Expected control according to Colby's Formula













TABLE 4







Table 4 demonstrates synergy on weeds using the combination of L-glufosinate,


imazethapyr and carfentrazone. The percentage efficacy was calculated for 3, 7, 14, 21, 28, 35


days of applications (DAA). The target weed was weedy Eleusine indica, and the concentration


of the herbicide and the results are recorded the table 4 below:













Active
3 DAA
7 DAA
14 DAA
21 DAA
28 DAA
35 DAA



















ingredient,
Control

Control

Control

Control

Control

Control



dose a.i., g/h
%
Colby*
%
Colby*
%
Colby*
%
Colby*
%
Colby*
%
Colby*






















L-glufosinate,
15

43.3

41.3

37.3

28.3

25.3



150














Imazethapyr,
3.7

8.3

12

12.7

12.7

10



75.0














Carfentrazone,
8.7

14

12.3

11

7.7

0



7.5














L-glufosinate,
33.3
25.3
69.3
55.3
84.3
54.7
86.7
51.3
84.7
42.2
82.7
32.8


150 +














imazethapyr,














75 +














carfentrazone,














7.5





*Expected control according to Colby's Formula













TABLE 5







Table 5 demonstrates synergy on weeds using the combination of L-glufosinate,


imazethapyr and carfentrazone. The percentage efficacy was calculated for 7, 14, 21, 28, 35


days of applications (DAA). The target weed was weedy Spermacocelatifolia, and the


concentration of the herbicide and the results are recorded the table 5 below:












Active
7 DAA
14 DAA
21 DAA
28 DAA
35 DAA

















ingredient,
Control

Control

Control

Control

Control



dose a.i., g/h
%
Colby*
%
Colby*
%
Colby*
%
Colby*
%
Colby*




















L-glufosinate,
35

56.7

56.7

58.3

58.3



150












Imazethapyr,
13.3

30

36.7

30

26.7



75.0












Carfentrazone,
58.3

64.3

64.3

64.3

63.3



7.5












L-glufosinate,
89
76.5
99.7
89.2
99.7
90.2
100
89.6
100
88.8


150 +












imazethapyr,












75 +












carfentrazone,












7.5





*Expected control according to Colby's Formula













TABLE 6







Table 6 demonstrates synergy on weeds using the combination of L-glufosinate,


imazethapyr and carfentrazone. The percentage efficacy was calculated for 7, 14, 21, 28, 35


days of applications (DAA). The target weed was weedy Brachiaria decumbens, and the


concentration of the herbicide and the results are recorded the table 6 below:












Active
7 DAA
14 DAA
21 DAA
28 DAA
35 DAA

















ingredient,
Control

Control

Control

Control

Control



dose a.i., g/h
%
Colby*
%
Colby*
%
Colby*
%
Colby*
%
Colby*




















L-glufosinate,
46

54.3

53.3

48.3

42



150












Imazethapyr,
10

10

15

10

5



75.0












Carfentrazone,
14

16.7

15

5

0



7.5












L-glufosinate,
66
58.2
84.3
65.7
90
66.3
87.7
55.8
85.7
44.9


150 +












imazethapyr,












75 +












carfentrazone,












7.5





*Expected control according to Colby's Formula













TABLE 7







Table 7 demonstrates synergy on weeds using the combination of L-


glufosinate, triclopyr and saflufenacil. The percentage efficacy was


calculated for 7 days of applications (DAA). The target weed was


weedy Glycine max, and the concentration of the herbicide and the


results are recorded the table 7 below:









7 DAA









Active ingredient, dose a.i., g/h
Control %
Colby*












L-glufosinate, 150
71.9



Saflufenacil, 30
75.4



Triclopyr, 228
67.9



L-glufosinate, 150 + Saflufenacil, 30 +
100
97.7


Triclopyr, 228





*Expected control according to Colby's Formula













TABLE 8







Table 8 demonstrates synergy on weeds using the combination of


L-glufosinate, triclopyr and saflufenacil. The percentage efficacy


was calculated for 3 days of applications (DAA). The target weed


was Brachiaria decumbens, and the concentration of the herbicide


and the results are recorded the table 8 below:









7 DAA









Active ingredient, dose a.i., g/h
Control %
Colby*












L-glufosinate, 150
66.2



Saflufenacil, 30
30



Triclopyr, 228
0



L-glufosinate, 150 + Saflufenacil, 30 +
77.5
76.3


Triclopyr, 228







*Expected control according to Colby's Formula













TABLE 9







Table 9 demonstrates synergy on weeds using the combination of L-glufosinate, 2,4 D


and saflufenacil. The percentage efficacy was calculated for 21, 28 and 35 days of applications


(DAA). The target weed was weedy Glycine max, and the concentration of the herbicide and


the results are recorded the table 9 below:










Active ingredient,
21 DAA
28 DAA
35 DAA













dose a.i., g/h
Control %
Colby*
Control %
Colby*
Control %
Colby*
















L-glufosinate, 150
57.5

50.6

47.5



Saflufenacil, 30
63.2

52.5

50.7



2,4 D, 228
49.3

43.8

41



L-glufosinate, 150 +
100
92
100
86.8
100
84.7


Saflufenacil, 30 +








2,4 D, 228





*Expected control according to Colby's Formula













TABLE 10







Table 10 demonstrates synergy on weeds using the combination of L-glufosinate,


imazapic and imazapyr. The percentage efficacy was calculated for 3, 7, 14, 21, 28 and 35 days


of applications (DAA). The target weed was Borreria verticillata, and the concentration of the


herbicide and the results are recorded the table 10 below:



















Active

























ingredient,
3 DAA
7 DAA
14 DAA
21 DAA
28 DAA
35 DAA




















Control

Control

Control

Control

Control

Control



dose a.i., g/h
%
Colby*
%
Colby*
%
Colby*
%
Colby*
%
Colby*
%
Colby*






















L-glufosinate, 150
50

80

95

90

90

85



Imazapic and Imazap
15

20

30

30

40

55



yr, 31.5 + 10.5














L-glufosinate, 150
70
57.5
95
84
100
96.5
100
93
100
94
100
93.25


Imazapic and














Imazapyr, 31.5 + 10.5





* Expected control according to Colby's Formula













TABLE 11







Table 11 demonstrates synergy on weeds using the combination


of L-glufosinate, imazapic and imazapyr. The percentage efficacy


was calculated for 3 days of applications (DAA). The target


weed was Amaranthus viridus, and the concentration of the


herbicide and the results are recorded the table 11 below:









3 DAA









Active ingredient, dose a.i., g/h
Control %
Colby*





L-glufosinate, 150
50



Imazapic and Imazapyr, 31.5 + 10.5
35



L-glufosinate, 150 + Imazapic and
70
67.5


Imazapyr, 31.5 + 10.5





*Expected control according to Colby's Formula













TABLE 12







Table 12 demonstrates synergy on weeds using the combination of L-glufosinate,


imazapic and imazapyr. The percentage efficacy was calculated for 3, 7, 14 days of applications


(DAA). The target weed was Eleusine indica, and the concentration of the herbicide and the


results are recorded the table 12 below:













Active
















ingredient, dose
3 DAA
7 DAA
14 DAA













a.i., g/h
Control %
Colby*
Control %
Colby*
Control %
Colby*
















L-glufosinate, 150
40

50

40



Imazapic and
10

15

40



Imazapyr, 31.5 + 10.5








L-glufosinate,
50
46
65
57.5
70
64


150 + Imazapic








and Imazapyr,








31.5+ 10.5





*Expected control according to Colby's Formula






The results in table 3-12 demonstrate the synergy between L-glufosinate, and two herbicides. The large difference between the observed and the expected efficacy clearly demonstrates the synergistic effect of the combination.


While the foregoing written description of the invention enables one of ordinary skill to make and use what is considered presently to be the best mode thereof, those of ordinary skill will understand and appreciate the existence of variations, combinations, and equivalents of the specific embodiment, method, and examples herein. The invention should therefore not be limited by the above-described embodiment, method, and examples, but by all embodiments and methods within the scope and spirit of the invention.

Claims
  • 1. An herbicidal combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from: (a) nitrophenyl ether class of herbicides;(b) imidazolinone class of herbicides;(c) organophosphorous class of herbicides;(d) dicarboximide class of herbicides;(e) phenoxyacetic class of herbicides;(f) pyridine class of herbicides;(g) cyclohexene oxime class of herbicides;(h) aryloxyphenoxypropionic class of herbicides;(i) triazolone class of herbicides; and/or(j) uracil class of herbicides.
  • 2. The combination as claimed in claim 1, wherein the glufosinate, salts or esters thereof is L-glufosinate, salts or esters thereof.
  • 3. The combination as claimed in claim 1, wherein the second and third herbicides are selected from within the different classes of herbicides.
  • 4. The combination as claimed in claim 1, wherein the second and third herbicides are selected from within the same class of herbicides.
  • 5. The combination as claimed in claim 1, wherein a weight ratio of glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:100:100 to 100:1:1.
  • 6. The combination as claimed in claim 1, wherein a weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:100 to 100:1.
  • 7. The combination as claimed in claim 1, wherein: (a) the nitrophenyl ether class herbicide is selected from the group consisting of oxyfluorfen, acifluorfen, aclonifen, bifenox, chlomethoxyfen, chlornitrofen, etnipromid, fluorodifen, fluoroglycofen, fluoronitrofen, fomesafen, fucaomi, furyloxyfen, halosafen, lactofen, nitrofen, nitrofluorfen, and combinations thereof;(b) the imidazolinone class herbicide is selected from the group consisting of imazethapyr, imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, and combinations thereof;(c) the organophosphorous class herbicide is selected from the group consisting of glyphosate, amiprofos-methyl, amiprophos, anilofos, bensulide, bilanafos, butamifos, clacyfos, 2,4-DEP, DMPA ((O-(2,4-dichlorophenyl)O-methyl isopropylphosphoramidothioate)), EBEP (ethyl bis(2-ethylhexyl)phosphinate), fosamine, glufosinate-P, piperophos, and combinations thereof;(d) the dicarboximide class herbicide is selected from the group consisting of cinidon-ethyl, flumezin, flumiclorac, flumioxazin, flumipropyn, and combinations thereof;(e) the phenoxyacetic class herbicide is selected from the group consisting of clacyfos, 4-CPA (p-Chlorophenoxyacetic acid), 2,4-D, 3,4-DA, MCPA (2-methyl-4-chlorophenoxyacetic acid), MCPA-thioethyl, 2,4,5-T and combinations thereof;(f) the pyridine class herbicide is selected from the group consisting of aminopyralid, cliodinate, clopyralid, diflufenican, dithiopyr, florpyrauxifen, flufenican, fluroxypyr, halauxifen, haloxydine, picloram, picolinafen, pyriclor, pyroxsulam, thiazopyr, triclopyr, xyloxadine, and combinations thereof;(g) the cyclohexene oxime class herbicide is selected from the group consisting of alloxydim, butroxydim, clethodim, cloproxydim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim, and combinations thereof;(h) the aryloxyphenoxypropionic class herbicide is selected from the group consisting of chlorazifop, clodinafop, clofop, cyhalofop, diclofop, fenoxaprop, fenoxaprop-P, fenthiaprop, fluazifop, fluazifop-P, haloxyfop, haloxyfop-P, isoxapyrifop, metamifop, propaquizafop, quizalofop, quizalofop-P, quizalofop-P-tefuryl, quizalofop-ethyl, trifop, and combinations thereof;(i) the triazolone class herbicide is selected from the group consisting of amicarbazone, bencarbazone, carfentrazone, flucarbazone, ipfencarbazone, propoxycarbazone, sulfentrazone, thiencarbazone and combinations thereof; and/or(j) the uracil class herbicide is selected from the group consisting of bromacil, isocil, lenacil, terbacil, benzfendizone, butafenacil, epyrifenacil, flupropacil, saflufenacil, tiafenacil, and combinations thereof.
  • 8. The combination as claimed in claim 1, wherein: (a) the nitrophenyl ether class herbicide is oxyfluorfen;(b) the imidazolinone class herbicide is selected from imazethapyr, imazapic, imazapyr or combinations thereof;(c) the organophosphorous class of herbicide is glyphosate;(d) the dicarboximide class herbicide is flumioxazin;(e) the phenoxyacetic class herbicide is 2,4-D;(f) the pyridine class herbicide is triclopyr;(g) the cyclohexene oxime class herbicide is clethodim;(h) the aryloxyphenoxypropionic class herbicide is haloxyfop;(i) the triazolone class herbicide is carfentrazone; and/or(j) the uracil class herbicide is saflufenacil.
  • 9. The combination as claimed in claim 1, wherein glufosinate, salts or esters thereof, is present in an amount in a range of 100 to 400 g ai/L.
  • 10. The combination as claimed in claim 1, wherein: (a) the nitrophenyl ether class herbicide present in an amount in the range of 100 to 400 g ai/L;(b) the imidazolinone class herbicide present in an amount in the range of 10 to 250 g ai/L or 100-1000 g ai/L;(c) the organophosphorous class herbicide present in an amount in the range of 200 to 1000 g ai/L;(d) the dicarboximide class herbicide present in an amount in the range of 200-800 g ai/L;(e) the phenoxyacetic class herbicide present in an amount in the range of 200 to 1200 g ai/L;(f) the pyridine class herbicide present in an amount in the range of 300-1000 g ai/L;(g) the cyclohexene oxime class herbicide present in an amount in the range of 100-400 g ai/L;(h) the aryloxyphenoxypropionic class herbicide present in an amount in the range of 1 to 250 g ai/L;(i) the triazolone class herbicide present in an amount in the range of 100-800 g ai/L; and/or(j) the uracil class herbicide present in an amount in the range of 1-1000 g ai/L.
  • 11. An herbicidal composition comprising the combination as claimed in claim 1, and at least one agrochemically suitable excipient.
  • 12. The composition as claimed in claim 11, wherein the composition is a tank-mix composition.
  • 13. A method of controlling the growth of undesirable vegetation at a locus, the method comprising treating the locus with an herbicidal combination or a composition as claimed in claim 1.
  • 14. The method as claimed in claim 13, wherein the glufosinate is applied at an application rate of 50-350 g ai/h.
  • 15. The method as claimed in claim 13, wherein at least two herbicides are selected from (a) the nitrophenyl ether class herbicide applied at an application rate of 5-250 g ai/h;(b) the imidazolinone class herbicide applied at an application rate of 5-200 g ai/h;(c) the organophosphorous class herbicide applied at an application rate of 100-800 g ai/h;(d) the dicarboximide class herbicide applied at an application rate of 1 to 200 g ai/h;(e) the phenoxyacetic class herbicide applied at an application rate of 50-400 g ai/h;(f) the pyridine class herbicide applied at an application rate of 50-500 g ai/h;(g) the cyclohexene oxime class herbicide applied at an application rate of 1-150 g ai/h;(h) the aryloxyphenoxypropionic class herbicide applied at an application rate of 1-150 g ai/h;(i) the triazolone class herbicide applied at an application rate of 0.5-100 g ai/h; and/or(j) the uracil class herbicide applied at an application rate of 10-150 g ai/h.
  • 16. An herbicidal combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a pyridine class herbicide and an uracil class herbicide.
  • 17. The combination as claimed in claim 16, wherein the pyridine class herbicide is triclopyr.
  • 18. The combination as claimed in claim 16, wherein the uracil class herbicide is saflufenacil.
  • 19. An herbicidal combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a phenoxyacetic class herbicide and an uracil class herbicide.
  • 20. The combination as claimed in claim 19, wherein the phenoxyacetic class herbicide is 2,4-D.
  • 21. The combination as claimed in claim 19, wherein the uracil class herbicide is saflufenacil.
  • 22. An herbicidal combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and two herbicides selected from the imidazolinone class herbicides.
  • 23. The combination as claimed in claim 22, wherein the imidazolinone herbicides are imazapic and imazapyr.
Priority Claims (1)
Number Date Country Kind
202121047126 Oct 2021 IN national
PCT Information
Filing Document Filing Date Country Kind
PCT/IN2022/050921 10/17/2022 WO